Core Viewpoint - Analysts forecast Altria's quarterly earnings at $1.17 per share, reflecting a year-over-year increase of 1.7%, while revenues are expected to decline by 1.7% to $4.64 billion [1] Earnings Projections - The consensus EPS estimate has been adjusted downward by 1.9% over the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong link between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Net revenue- All Other/ Financial Services' at $36.00 million, representing an increase of 89.5% year-over-year [5] - 'Revenues net of excise taxes- Oral tobacco products' are projected at $633.90 million, showing a year-over-year change of 1.3% [5] - 'Revenues net of excise taxes- Smokeable Products' are expected to be $3.97 billion, reflecting a decline of 2.6% from the previous year [6] Operating Income - 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' is estimated at $448.82 million, compared to $435 million reported in the same quarter last year [6] - 'Adjusted OCI- Smokeable Products' is predicted to reach $2.48 billion, slightly up from the year-ago value of $2.45 billion [7] Market Performance - Altria's shares have increased by 1.4% over the past month, contrasting with a decline of 5.1% in the Zacks S&P 500 composite [7] - With a Zacks Rank 4 (Sell), Altria is expected to underperform the overall market in the near future [7]

Core Viewpoint - The article emphasizes the resilience of Philip Morris International, S&P Global, and Walmart as investment options amidst market volatility and tariff concerns, suggesting that investors should focus on dividend growth stocks that are insulated from economic downturns [1][2]. Philip Morris International - Philip Morris International (PMI) was spun off from Altria in 2008, allowing it to focus on its overseas business while Altria dealt with domestic challenges [3]. - From 2008 to 2024, PMI's adjusted earnings per share (EPS) grew at a compound annual rate of 4.4%, driven by price increases and cost-cutting measures, alongside a shift towards smoke-free products [4]. - PMI has consistently raised its dividend since the split, currently offering a forward yield of 3.6% with a trailing payout ratio of 88%, indicating potential for future increases [5]. - Analysts project adjusted EPS growth of 9% in 2025 and 10% in 2026, with a reasonable valuation at 21 times forward earnings [5]. S&P Global - S&P Global provides essential financial data and analytics services to approximately 80% of Fortune 500 companies, utilizing AI-driven tools to enhance its offerings [6]. - The company is insulated from tariffs as it offers services rather than physical goods, making its services more valuable in turbulent markets [7]. - Despite a temporary slowdown in its credit ratings business due to high interest rates, S&P Global is expected to recover as rates decline [7]. - The company has a forward yield of 0.9% and has raised its dividend for 52 consecutive years, with a low trailing payout ratio of 29% [8]. - Analysts anticipate EPS growth of 9% in 2025 and 12% in 2026, with a forward price-to-earnings ratio of 26, indicating it is not overly expensive [8]. Walmart - Walmart serves 270 million customers weekly across 10,750 stores and online marketplaces in 19 countries, providing it with significant scale to mitigate tariff impacts [9]. - Many of Walmart's suppliers pre-shipped products to the U.S. before tariffs were implemented, and the company can negotiate lower prices or adjust retail prices to manage costs [10]. - Walmart has a forward yield of 1.1% and has raised its dividend for 52 consecutive years, maintaining a low payout ratio of 34% [11]. - Analysts expect adjusted EPS growth of 5% in fiscal 2026 and 12% in fiscal 2027, with a forward price-to-earnings ratio of 31, suggesting that its core strengths may justify the higher valuation [11].

There's no ignoring it. President Trump's tariffs and trade threats are roiling the markets, sending the S&P 500 into a correction for the first time since 2022. The tariffs announced today were just the latest move fueling investor uncertainty.Meanwhile, consumer sentiment is rapidly falling, and businesses are increasingly fearful as the manufacturing sector just fell into a contraction, according to the March ISM survey. Much of the economy is at risk from tariffs and the impact of a weakening economy. F ...

Core Viewpoint - Altria's stock price has appreciated by 43.48% since early 2024, driven by a bullish thesis based on two core arguments [1]. Group 1: Stock Performance - The stock price increase of 43.48% occurred before any dividends were accounted for [1]. Group 2: Investment Thesis - The bullish thesis on Altria is based on two main arguments, although the specific arguments are not detailed in the provided text [1].

Core Insights - Altria is facing significant challenges as cigarette demand declines, which is its primary revenue source, while management emphasizes potential opportunities that may indicate the company is lagging behind [1][10] Business Overview - Altria's main business revolves around cigarette sales, which constituted 88% of its revenues in 2024, with cigarettes making up nearly 98% of smokeable tobacco volumes [2] Financial Performance - Cigarette volumes have been declining for years, with a notable drop of 10.2% in 2024; however, price increases have mitigated revenue losses, resulting in a 1.3% revenue decline and a 3.4% rise in adjusted earnings [3] - The company raised its dividend in 2024, reflecting a high dividend yield of approximately 7%, which attracts dividend investors despite the negative trends in its core business [4] Market Trends - The number of smokers in the U.S. decreased from 34 million in 2019 to 28 million in 2024, while non-combustible product users remained stable at around 8 million; however, non-combustible-only consumers surged from 11 million to 18 million, marking a 60% growth [5][6] Strategic Missteps - Altria has made several strategic errors, including spinning off Philip Morris International, which left it vulnerable in a declining cigarette market and created new competition in the non-combustible space [7] - Investments in Juul and a marijuana company resulted in significant write-offs, and while the recent acquisition of NJOY shows better sales performance, it faces patent litigation with Juul [8] Growth Opportunities - Non-combustible products are increasingly important, yet Altria has not capitalized on this trend, with non-smokeable products accounting for only 11.7% of revenues in 2024, down from 12.4% in 2019, despite the non-combustible category growing significantly [9][10]

Company Performance - Altria's stock closed at $56.71, reflecting a -1.63% change from the previous day's closing price, underperforming the S&P 500 which gained 0.16% [1] - Over the past month, Altria's shares increased by 4.34%, outperforming the Consumer Staples sector which saw a loss of 0.69% and the S&P 500's loss of 3.59% [2] Upcoming Earnings - Altria is expected to report an EPS of $1.19, representing a 3.48% increase compared to the same quarter last year, with a revenue forecast of $4.66 billion, indicating a 1.11% decrease from the same quarter last year [3] - For the entire fiscal year, earnings are projected at $5.32 per share and revenue at $20.48 billion, reflecting changes of +3.91% and +0.18% respectively from the prior year [4] Analyst Estimates and Rankings - Recent changes in analyst estimates for Altria are crucial as they indicate evolving short-term business trends, with positive revisions suggesting analyst optimism regarding the company's profitability [4] - The Zacks Rank system, which includes estimate changes, currently ranks Altria at 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [6] Valuation Metrics - Altria has a Forward P/E ratio of 10.84, which is in line with the industry average, and a PEG ratio of 3.07, compared to the tobacco industry average PEG ratio of 2.82 [7] Industry Context - The Tobacco industry, part of the Consumer Staples sector, holds a Zacks Industry Rank of 78, placing it in the top 32% of over 250 industries, indicating strong performance potential [8]

Core Viewpoint - The article compares Altria and Philip Morris International, highlighting their differing business models, financial performance, and growth prospects in the tobacco industry, particularly in the context of their transitions to smoke-free products. Business Model Comparison - Altria and Philip Morris, despite sharing cigarette brands, have different business models, with Altria focusing on the U.S. market and Philip Morris on international markets [2][3] - Philip Morris has successfully developed next-generation products like Iqos and Zyn, gaining significant market share, while Altria has struggled with its investments in Juul and cannabis [4][5][6] Financial Performance - In 2024, Altria's revenue declined by 1.9% to $24 billion, primarily due to a 10.2% drop in cigarette shipment volume, although it maintained a high adjusted operating margin of 61.2% [8][9] - Philip Morris reported a 7.7% increase in revenue to $37.9 billion, with a 0.6% rise in international cigarette volume and a 16% increase in operating income [9] Dividend and Valuation - Altria offers a dividend yield of 7% and trades at a price-to-earnings ratio of 11.3, maintaining a strong reputation as a dividend payer [10][11] - Philip Morris has a lower dividend yield of 3.5% but a higher P/E ratio of 22, reflecting its faster growth and success in next-gen products [11] Growth Prospects - Altria is beginning to see growth from its investment in Njoy, but it continues to face revenue losses and challenges in its core cigarette business [12] - Philip Morris is experiencing growth in both its next-gen products and its cigarette business, indicating a more favorable long-term growth trajectory [12][13]

Group 1 - The article highlights that Trump has shifted towards a pro-cannabis stance since his election campaign, which could significantly benefit Altria (NYSE: MO) [1] - In August of the previous year, Trump expressed that tax dollars should not be wasted on arresting individuals for cannabis-related offenses [1] Group 2 - Aseity Research focuses on high-yield income investing combined with tech-driven growth, providing insights on stocks, ETFs, CEFs, and options strategies [1]

Core Insights - Altria and British American Tobacco offer attractive yields of 7.4% and 7.7% respectively, significantly higher than the S&P 500's 1.2% and the average consumer staples yield of 2.7% [1] - Both companies face a long-term decline in cigarette volumes, with Altria experiencing a more severe decline compared to British American Tobacco [2][4] Volume Trends - Altria's cigarette volume declined by 9.7% in 2022, 9.9% in 2023, and is projected to decline by 10.2% in 2024, indicating a worsening trend [3] - British American Tobacco's volume declined by 5.1% in 2022, 5.3% in 2023, and 5% in 2024, with the latter two figures excluding the impact of the sale of its Russian and Belarus businesses [4] Business Strategies - Both companies have responded to declining volumes by raising prices, which has allowed them to maintain and even grow dividends despite losing customers [5] - British American Tobacco's global diversification has helped mitigate the impact of volume declines, but it has acknowledged significant challenges in the U.S. market [6] Future Outlook - The tobacco industry faces a bleak future unless new growth platforms are identified to replace declining cigarette operations [7] - Both companies are exploring new business opportunities, such as vaping and pouches, to address the challenges posed by declining cigarette sales [8] Investment Considerations - For short-term income investors, British American Tobacco may be the preferred choice due to its higher yield and better volume performance [9] - Long-term investors may find both companies lacking in fundamental strength to justify investment in the tobacco sector [9]

Altria (MO 1.40%) isn't a household name in the consumer staples sector, but its main brand is probably one you know. Indeed, its Marlboro cigarette brand has a nearly 42% share of the U.S. cigarette market. Add in a 7.3% yield backed by a growing dividend, and you can see why investors would be attracted to Altria's shares. Could a $10,000 investment help get you to millionaire status? Maybe, but you need to balance the reward against the risk before jumping in.What does Altria do?Altria is a consumer stap ...